Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
35.44 USD | +3.05% | +1.63% | +21.94% |
19.03. | Morphic Holding ernennt Simon Cooper zum Chief Medical Officer | MT |
19.03. | Morphic Therapeutic ernennt Simon Cooper zum Chief Medical Officer | CI |
Kurzporträt
Mitarbeiterzahl: 121
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 55 | 01.07.15 | |
Bruce Rogers
PSD | President | 55 | 01.01.16 |
Marc Schegerin
DFI | Director of Finance/CFO | 48 | 06.04.20 |
Blaise Lippa
CTO | Chief Tech/Sci/R&D Officer | - | 01.06.15 |
Brihad Abhyankar
CTO | Chief Tech/Sci/R&D Officer | - | 06.04.22 |
Joanne Gibbons
LAW | General Counsel | - | 18.05.22 |
William DeVaul
LAW | General Counsel | 53 | 01.02.19 |
Aaron Pelta
PRN | Corporate Officer/Principal | - | 01.01.19 |
Robert Farrell
AUD | Comptroller/Controller/Auditor | 58 | 01.06.15 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Timothy Springer
FOU | Founder | 76 | 01.08.14 |
Director/Board Member | 68 | 01.06.19 | |
Joseph Slattery
BRD | Director/Board Member | 59 | 01.05.19 |
Amir Nashat
BRD | Director/Board Member | 51 | 01.06.17 |
Susannah Gray
BRD | Director/Board Member | 63 | 27.04.21 |
Martin Edwards
BRD | Director/Board Member | 68 | 04.12.20 |
Chairman | 76 | 01.04.16 | |
Nisha Nanda
BRD | Director/Board Member | 49 | 19.08.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 50 037 229 | 41 423 284 ( 82,78 %) | 0 | 82,78 % |
Unternehmenskontakt
Morphic Holding, Inc.
35 Gatehouse Drive A2
02451, Waltham
+781 996 0955
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+21.94% | 1.72 Mrd. | |
+8.95% | 45.97 Mrd. | |
+52.45% | 43.93 Mrd. | |
+7.50% | 42.34 Mrd. | |
-8.78% | 28.27 Mrd. | |
+17.80% | 27.18 Mrd. | |
-20.86% | 19.44 Mrd. | |
+14.24% | 13.83 Mrd. | |
+32.04% | 12.4 Mrd. | |
+9.87% | 11.45 Mrd. |
- Börse
- Aktien
- Aktie Morphic Holding, Inc. - Nasdaq
- Unternehmen Morphic Holding, Inc.